1. Кулаков В.И. Клинические рекомендации. Акушерство и гинекология. Под ред. В.И.Кулакова. М.: ГЭОТАР-Медиа, 2005; 34–7.
2. Прилепская В.Н., Острейкова Л.И. Ярина – научная брошюра. М., 2004; 12–4.
3. Теппермен Д., Теппермен Х. Физиология обмена веществ и эндокринной системы. М.: Мир. 1989; 12: 372–97.
4. Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 1989; 52: 703–25.
5. Clark AM, Thornley B, Tomlinson L et al. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998; 13: 1502–5.
6. Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28 (2): 341–59.
7. Mansour D. Experiences with Yasmin: the acceptability os a novel oral contraceptive and its effects on well-being. Eur J Contrac Reprod Health 2002; 7: 35–41.
8. Walter E, Beier S et al. Conception and pharmacodinamic profile of drospirenone. Sreroids 2003; 68: 891–905.